Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…
Enterprise Resource Planning
Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
• Orphan Drug Designation Granted to KB408 PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) — Krystal…
Perficient to Demonstrate Cloud Migration Expertise at Oracle CloudWorld
SAINT LOUIS–(BUSINESS WIRE)–Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s…
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in…
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in…
FUNKO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Funko, Inc. – FNKO
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…
SAP, OneRail, Kinaxis, Manhattan Associates and Other Supply Chain Leaders to Showcase Latest Innovations at Visibility 2023
FourKites partners are leveraging real-time supply chain visibility data to improve operations far beyond transportation…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Excision BioTherapeutics Announces Gene Therapy Publication of Pre-Clinical Data Supporting its First-in-Class CRISPR-Based Gene Therapy Candidate Designed to Functionally Cure HIV-1
Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates…
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress
CORAL GABLES, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance
For the three months ended June 30, 2023: Revenues of $793.0 million GAAP net income…
Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance
For the three months ended June 30, 2023: Revenues of $793.0 million GAAP net income…
HireRight Reports Second Quarter 2023 Results
– $192 million in Revenues – – Increasing Full-Year Adjusted EBITDA Outlook – – Repurchased…
Cellectis Provides Full Report for Second Quarter 2023 Financial Results
NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (the “Company”) (Euronext Growth: ALCLS-…
Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results
ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with…
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Macquarie Capital Names Advisory Veteran Joseph Gatto as Senior Advisor – Global Consumer and Retail
Joseph Gatto will work with Macquarie Capital’s global consumer and retail team to advise clients…
ECI Software Solutions Announces Scalable Deacom Offering to Help SMBs Digitally Transform Their Businesses
Deacom Essentials offers batch and process manufacturers a cost-effective, tailored ERP FORT WORTH, Texas–(BUSINESS WIRE)–ECI…